Inflation directly affects the prices of prescription drugs in the U.S., but the Inflation Reduction Act can help combat the soaring prices and make them accessible to patients. Key Takeaways: Drug prices are outpacing inflation Everything is getting more expensive, and drug prices are no...

Key Takeaways Most Americans support Medicare price reductions for prescription drugs Many Americans believe the government should be involved in setting price limits for prescription drugs Drug manufacturers and Big Pharma lobbyist groups have argued that lowering the prices of prescription...

Navigating the annual Open Enrollment season. It’s a formidable task, and just when you’ve selected a plan that feels right for you, the season rolls around again and you’re once again plunged into the murky waters of HSA versus high-deductible, provider networks and qualifying...

Open Enrollment is nearly upon us and if you are one of the millions of self-employed Americans, you may be starting to explore your health insurance options ahead of the coming Open Enrollment period. In recent years, an increasing number of workers in the United States have gone into business for...

If you are one of many Americans whose employer offers group health coverage or other health insurance options, you may already be considering which health plan best suits you and your family ahead of the 2022 Open Enrollment Period.  Each year, around half of the population of the United...

It’s that time of year when millions of Americans are starting to look into their health insurance coverage options ahead of the 2022 Open Enrollment period. With the relatively short sign-up period for coverage under the Affordable Care Act (ACA), also known as Obamacare, it’s...

The Trump Administration has finalized new rules changing the maximum length of short-term, limited duration health plans, a step it claims will increase health insurance options for Americans.  Issued by the US Departments of Health and Human Services (HHS), Labor and Treasury, the new...

“Change is coming to prescription drug pricing,” is the message from Health and Human Services (HHS) secretary Alex Azar, who made the comments at the annual meeting of 340B Health, a trade group for 340B hospitals.  At the meeting, he suggested the existing 340B system is in need...

Concern over the cost of cost of health care resulted in more than one-quarter (27 percent) of American adults forgoing medical treatment over concerns about their ability to pay, according to a recent report. The Federal Reserve’s Report on the Economic Well-Being of US Households in 2017...

Senior patients with diabetes could be more than $350 better off each year if a share of negotiated manufacturer rebates is passed on the patients at the point of sale, according to recent IHS Markit analysis commissioned by the Pharmaceutical Research and Manufacturers of America (PhRMA). Passing...

President Donald Trump has unveiled a “blueprint” to lower the price of prescription drugs in the United States. The plans include building on the existing administrative efforts of the US Food and Drug Administration (FDA) to increase generic drug approvals, reforms to the Medicare...

The high cost of prescription medication remains a major concern for a significant proportion of Americans, with eight out ten respondents to the latest Kaiser Health Tracking Poll describing prices as “unreasonable”. The results showed a rise in the proportion of the American public...

Annual per patient outpatient pharmacy costs at hospitals participating in the 340B Drug Discount Program are significantly higher than in non-340B hospitals, according to new analysis from the Pharmaceutical Research and Manufacturers of America (PhRMA). The analysis, prepared by Milliman and...

Patients with health plans with value-based contracts for diabetes, high cholesterol, and HIV medication benefited from significantly cheaper co-pays than patients on other plans, according to new data from the Pharmaceutical Research and Manufacturers of America (PhRMA). On average, these...

Health insurance customers generally enjoy two main benefits with regards to prescription drugs. Firstly, insurance policies often entitle holders to cheaper medication. Second, a low co-pay is usually set, although this can vary between policies and between drugs. When you require a prescription,...

Governor Edmund G Brown Jr of California has signed legislation SB 17 aimed at improving the transparency of prescription drug prices in the Golden State. It is hoped the Drug Price Transparency Bill, authored by Senator Ed Hernandez, will curb price hikes and help patients struggling with...

More than one-quarter (27 percent) of patients between 50 and 80 years of age find the cost of their prescription medication a burden, according to the latest National Poll on Healthy Aging conducted by the University of Michigan. The study looked at responses from approximately 2,000 people within...

Nevada could become the first state in the United States. to allow all residents to buy into the Medicaid program, no matter what their income level. The state's legislature passed the bill earlier this month, but the final decision rests with Republican governor Brian Sandoval, who has the power...

Many patients with chronic obstructive pulmonary disease (COPD) who have Medicare Part D struggle to pay for medication and inhalers, it has been suggested. A report published in the Journal of the American Medical Association (JAMA) revealed one in nine Medicare beneficiaries have COPD. The...

Insured patients may lose prescription drug cover following yesterday's passing of the American Health Care Act (AHCA) by the US House of Representatives. The legislation includes provisions allowing states to opt out of certain protections offered under the Affordable Care Act (ACA). If passed by...